Skip to main content
Equibles
HR logo

HR · Healthcare Realty Trust Inc · Metrics

Track HR — free

Use HR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.26 -0.14 (-0.76%) At close · Sep 18
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$6.31B
Shares
342.72M

HR metrics

71 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.26
Market cap
$6.31B

Price action

20 metrics
Price change (1W)
-3.4%
Price change (30D)
-5.8%
Price change (3M)
-7.7%
Price change (6M)
+6.0%
Price change (YTD)
+7.7%
Price change (1Y)
+1.0%
Trailing year
Price change (5Y)
-39.8%
52-week high
$21.87
52-week low
$16.34
Change from 52-week high
-16.5%
Change from 52-week low
+11.8%
Annualized volatility
19.3%
Annualized volatility (3M)
17.0%
Beta
0.1
RSI (14D)
23.5
Price vs SMA 50
-8.2%
Price vs SMA 200
-2.7%
Avg volume (3M)
3.62M
Relative volume
2.2
Average dollar volume
$72.60M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
342.72M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.1×
reciprocal yield 11.0%
EV / EBITDA
20.4×
reciprocal yield 4.9%
EV / EBIT
60.5×
reciprocal yield 1.7%
P / sales
5.5×
reciprocal yield 18.2%
P / book
1.5
reciprocal yield 66.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.1%
P / FCF
—
P / operating cash flow
14.3
reciprocal yield 7.0%
Earnings yield
-1.4%

Historical valuation

8 metrics
P / E historical average (3Y)
138.6×
reciprocal yield 0.7%
P / E historical average (5Y)
138.6×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
8.7×
reciprocal yield 11.5%
EV / revenue historical average (5Y)
10.4×
reciprocal yield 9.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
5.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-7.6%
Gross profit (TTM)
—
Operating profit (TTM)
$143.69M
Net income (TTM)
−$86.92M
Trailing 12 months
Diluted EPS (TTM)
$-0.26
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$13.13

Growth

11 metrics
Revenue growth YoY
-5.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.14B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-2.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.2%
Revenue CAGR (5Y)
+18.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-19.5%
FCF CAGR (5Y)
-3.4%

Quality

14 metrics
Return on equity
-2.1%
Return on assets
-1.0%
Debt / equity
1.0
Current ratio
—
EBITDA (TTM)
$425.84M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
5.6
Return on invested capital
—
Trailing 12 months
Net cash
−$4.15B
Latest balance sheet
Cash & equivalents
$18.99M
Total assets
$9.00B
Total debt
$4.17B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$441.15M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$20.43M
R&D / revenue
—
Stock compensation / revenue
1.8%

Ownership (13F)

3 metrics
13F filers
461
13F filer change QoQ
+12
Institutional ownership
111.6%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$926,184
Insider-sentiment score
34 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1360604 CUSIP 42226K105 13F (30d) 12 filings 11 filers Visit website Investor relations